Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reevaluation of transient ischemic attacks as a risk factor for early mortality.

G Howard1, G W Evans, J L Thomas

  • 1Department of Public Health Sciences, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27103.

Stroke
|May 1, 1991
PubMed
Summary

Transient ischemic attack (TIA) may not independently increase mortality risk. Patients with TIA have similar survival rates to those with comparable risk factors, suggesting coexisting conditions are the primary drivers of poor outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Designing e-consent protocols for pragmatic clinical trials: case studies from a UKCRC clinical trials unit.

Trials·2024
Same author

Timing of procedural stroke and death in asymptomatic patients undergoing carotid endarterectomy: individual patient analysis from four RCTs.

The British journal of surgery·2020
Same author

Cells respond to deletion of CAV1 by increasing synthesis of extracellular matrix.

PloS one·2018
Same author

Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Association of stroke risk biomarkers with stroke symptoms: the Reasons for Geographic and Racial Differences in Stroke cohort.

Journal of thrombosis and haemostasis : JTH·2016

Area of Science:

  • Neurology
  • Cardiology
  • Epidemiology

Background:

  • Transient ischemic attack (TIA) is widely considered a significant risk factor for cardiovascular morbidity and mortality.
  • This belief is often based on comparisons with general population data, potentially overlooking prevalent comorbidities in TIA patients.
  • Comorbidities like ischemic heart disease, hypertension, and diabetes are common in TIA patients and are known risk factors for mortality.

Purpose of the Study:

  • To investigate whether transient ischemic attack (TIA) is an independent risk factor for cardiovascular mortality.
  • To compare the survival rates of TIA patients with a control group having similar cardiovascular risk factor profiles.
  • To determine if TIA itself, or its associated comorbidities, contributes more significantly to patient prognosis.

Main Methods:

Related Experiment Videos

  • A retrospective study comparing survival of 336 patients post-transient ischemic attack (TIA).
  • A control group of 6,710 patients evaluated for cardiac catheterization with similar risk factor profiles was used for comparison.
  • Survival estimates were analyzed both unadjusted and adjusted for key cardiovascular risk factors.

Main Results:

  • No significant difference in survival rates was observed between patients who experienced a transient ischemic attack (TIA) and the control group.
  • Three-year survival estimates, after risk factor adjustment, were 94% for TIA patients and 91% for controls.
  • These findings indicate that TIA may not be an independent predictor of mortality when controlling for other risk factors.

Conclusions:

  • Transient ischemic attack (TIA) may not be an independent risk factor for mortality.
  • TIA serves as an important indicator, identifying patients who are already at increased risk due to coexisting cardiovascular conditions.
  • Clinical management should focus on addressing the underlying comorbidities in patients presenting with TIA to improve long-term outcomes.